BB Biotech AG (XSWX:BION) OCF Margin %: -2,193.24% (As of Mar. 2026)


XSWX:BION BB Biotech AG XSWX:BION
33 GF Score
Price CHF47.80
! 3 Warning Signs
View Full Analysis

What is BB Biotech AG OCF Margin %?

BB Biotech AG XSWX:BION +2.14% 33 OCF Margin % is -2,193.24% as of Mar. 2026. GuruFocus rates XSWX:BION with a GF Score™ of 33/100. The stock has 3 warning signs investors should review. Among 960 Biotechnology companies, BB Biotech AG ranks better than 95.21% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. BB Biotech AG's Cash Flow from Operations for the three months ended in Mar. 2026 was CHF373.7 Mil. BB Biotech AG's Revenue for the three months ended in Mar. 2026 was CHF-17.0 Mil. Therefore, BB Biotech AG's OCF Margin % for the quarter that ended in Mar. 2026 was -2,193.24%.

As of today, BB Biotech AG's current OCF Yield % is 15.67%.

The historical rank and industry rank for BB Biotech AG's OCF Margin % or its related term are showing as below:

XSWX:BION' s OCF Margin % Range Over the Past 10 Years
Min: -109.37   Med: 27.65   Max: 369.99
Current: 48.1

During the past 13 years, the highest OCF Margin % of BB Biotech AG was 369.99%. The lowest was -109.37%. And the median was 27.65%.

XSWX:BION's OCF Margin % is ranked better than
95.21% of 960 companies
in the Biotechnology industry
Industry Median: -68.59 vs XSWX:BION: 48.10

BB Biotech AG OCF Margin % Related Terms

BB Biotech AG OCF Margin % Historical Data

* Premium members only.

The historical data trend for BB Biotech AG's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BB Biotech AG OCF Margin % Chart

BB Biotech AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.92 -65.81 -109.37 369.99 52.66

BB Biotech AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -120.99 63.98 14.04 3.40 -2,193.24

XSWX:BION vs VRTX, REGN, ALNY: OCF Margin % Comparison

For the Biotechnology subindustry, BB Biotech AG's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BB Biotech AG OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BB Biotech AG's OCF Margin % distribution charts can be found below:

* The bar in red indicates where BB Biotech AG's OCF Margin % falls into.


XSWX:BION
33GF Score
BB Biotech AG XSWX:BION
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BB Biotech AG OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

BB Biotech AG's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=309.145/587.007
=52.66 %

BB Biotech AG's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=373.707/-17.039
=-2,193.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -2,193.24% mean?
BB Biotech AG (XSWX:BION) has a OCF Margin % of -2,193.24% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on BB Biotech AG and its competitors. According to the industry distribution chart, BB Biotech AG ranks #46 out of 960 companies in the Biotechnology industry, placing it in the top 4.8%.
Is BB Biotech AG's OCF Margin % too high?
BB Biotech AG's current OCF Margin % is -2,193.24%. Based on the distribution chart, BB Biotech AG ranks #46 out of 960 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, BB Biotech AG has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does BB Biotech AG's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BB Biotech AG ranks #46 out of 960 companies for OCF Margin %. This places BB Biotech AG in the top 5% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on BB Biotech AG and its competitors. BB Biotech AG's current OCF Margin % is -2,193.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BB Biotech AG stock overvalued right now?
BB Biotech AG (XSWX:BION) has a current OCF Margin % of -2,193.24%. The current OCF Margin % is -2,193.24%. BB Biotech AG's overall GF Score™ is 33/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For BB Biotech AG (XSWX:BION), the current OCF Margin % is -2,193.24% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BB Biotech AG Business Description

Address Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. Geographically company operates in the USA, Netherlands, Singapore, Great Britain, Canada, Switzerland, Curacao, and British Virgin Island.
33GF Score

Get the complete analysis for XSWX:BION

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF47.80
Price